Announced

PAG, Samara Capital and CX Partners to acquire a 70% stake in Anjan Drug for $70m.

Synopsis

Private equity firms PAG, Samara Capital and CX Partners offered to acquire a 70% stake in Anjan Drug, which supplies active pharmaceutical ingredients for central nervous system therapies, for $70m. “The acquisition is part of the PAG-led consortium’s strategy to create a best-in-class platform for the development and production of bulk drug ingredients,” PAG.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US